Search Tag: prostate cancer

2014 08 Dec

According to a study published in JAMA, prescriptions for bisphosphonates, a class of drugs used to strengthen bone for men on androgen deprivation therapy (ADT) and for those at high risk of subsequent fractures, remain low despite guidelines recommending their use.   ADT is widely used in men suffering from prostate cancer. Common adverse effects...Read more

2014 04 Oct

A new study has identified a biomarker living beside the KLK3 gene that can predict which GS7 prostate cancer patients will have a more aggressive form of cancer, according to a Science Newsline report. The KLK3 gene is located on chromosome 19 and is responsible for encoding the prostate-specific antigen (PSA). Results of the study published in...Read more

2014 05 Aug

The company marketing Ablatherm Integrated Imaging High Intensity Focused Ultrasound (HIFU), used to treat low-risk prostate cancer, has failed to get the nod of U.S. Food and Drug Administration (FDA) on its premarket approval application. HIFU, which has been used in other countries for about 15 years, is marketed in Europe by EDAP TMS, a French...Read more

2013 14 Nov

  During the recently held EAU 13th Central European Meeting (CEM) in Prague, Czech Republic, the study entitled ‘Using Magnetic Resonance Imaging-Ultrasound (MRIUS)- guided prostate biopsy has high sensitivity to detect prostate abnormalities compared with transrectal ultrasonography (TRUS biopsy) of MRI positive findings’ won the first prize from...Read more